 | Why Biogen Stock Is on Fire Today - Motley Fool
www.fool.com - October 23 at 6:45 PM |
 | Drugmaker Alkermes cuts 160 jobs in effort to lower expenses
finance.yahoo.com - October 23 at 6:45 PM |
 | Biogen Alzheimer’s Revival Wins New Believers, Yet Doubts Linger - Bloomberg
www.bloomberg.com - October 23 at 1:44 PM |
 | Biogen CEO 'reasonably confident' once-doomed Alzheimer's drug will be granted FDA approval - CNBC
www.cnbc.com - October 23 at 1:44 PM |
| Is Biogen Stock A Buy After Rocketing On A New Analysis In Alzheimer's?
finance.yahoo.com - October 23 at 1:44 PM |
 | JPMorgan Chase & Co. Boosts Biogen (NASDAQ:BIIB) Price Target to $260.00
www.americanbankingnews.com - October 23 at 11:47 AM |
| Canaccord Genuity Raises Biogen (NASDAQ:BIIB) Price Target to $305.00
www.americanbankingnews.com - October 23 at 11:47 AM |
| Biogen (NASDAQ:BIIB) Price Target Raised to $260.00 at Credit Suisse Group
www.americanbankingnews.com - October 23 at 11:47 AM |
| Cowen Boosts Biogen (NASDAQ:BIIB) Price Target to $325.00
www.americanbankingnews.com - October 23 at 10:39 AM |
| Biogen (NASDAQ:BIIB) Given New $262.00 Price Target at Morgan Stanley
www.americanbankingnews.com - October 23 at 10:39 AM |
| Biogen (NASDAQ:BIIB) Upgraded to Outperform by Svb Leerink
www.americanbankingnews.com - October 23 at 10:39 AM |
| Biogen (NASDAQ:BIIB) Posts Quarterly Earnings Results, Beats Expectations By $0.90 EPS
www.americanbankingnews.com - October 23 at 9:43 AM |
| BMO Capital Markets Boosts Biogen (NASDAQ:BIIB) Price Target to $297.00
www.americanbankingnews.com - October 23 at 9:37 AM |
| Biogen soars as it seeks U.S. Alzheimer’s drug approval - Yahoo Finance
finance.yahoo.com - October 23 at 8:43 AM |
| D.E. Shaw, Arrowstreet Bets Pay Off With Biogen Drug Revival - Bloomberg
www.bloomberg.com - October 23 at 8:43 AM |
| Is Biogen a Buy After the Biggest Biotech Bombshell in Years? - Motley Fool
www.fool.com - October 23 at 8:43 AM |
| Biogen Alzheimer’s Revival Wins New Believers, Yet Doubts Linger
finance.yahoo.com - October 23 at 8:43 AM |
| Guggenheim Upgrades Biogen (NASDAQ:BIIB) to "Buy"
www.americanbankingnews.com - October 23 at 8:07 AM |
| HC Wainwright Raises Biogen (NASDAQ:BIIB) Price Target to $335.00
www.americanbankingnews.com - October 23 at 8:05 AM |
| Leerink Swann Upgrades Biogen (NASDAQ:BIIB) to Outperform
www.americanbankingnews.com - October 23 at 8:05 AM |
| Biogen Target of Unusually High Options Trading (NASDAQ:BIIB)
www.americanbankingnews.com - October 23 at 7:44 AM |
| Biogen Bombshell Triggers Annual-High Options Volume - Yahoo Finance
finance.yahoo.com - October 23 at 3:42 AM |
| Biogen Alzheimer’s Drug Is Far From Done Deal, Wall Street Says - Bloomberg
www.bloomberg.com - October 23 at 3:42 AM |
 | Biogen, Eisai revive plans for Alzheimer's drug, surprising market
uk.finance.yahoo.com - October 23 at 3:42 AM |
| Somewhat Favorable News Coverage Extremely Likely to Impact Biogen (NASDAQ:BIIB) Stock Price
www.americanbankingnews.com - October 23 at 3:14 AM |
 | The Dow Is Drifting, While Biogen Soars After Upbeat Earnings - Barron's
www.barrons.com - October 22 at 7:20 PM |
 | Biogen resurrects Alzheimer's drug; shares jump 37% - Reuters
www.reuters.com - October 22 at 7:20 PM |
| Biogen (BIIB) Up 40% on Alzheimer's Drug & More - Yahoo Finance
finance.yahoo.com - October 22 at 7:20 PM |
| Biogen resurrects Alzheimer's drug; shares jump 27% - Reuters
www.reuters.com - October 22 at 7:20 PM |
 | Biogen Inc. (BIIB) CEO Michel Vounatsos on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - October 22 at 4:53 PM |
 | Biogen reanalyzes studies, presses ahead on Alzheimer's drug
marketbeat.com - October 22 at 4:30 PM |
| UBS Group Increases Biogen (NASDAQ:BIIB) Price Target to $334.00
www.americanbankingnews.com - October 22 at 2:52 PM |
| Biogen (NASDAQ:BIIB) Rating Reiterated by Stifel Nicolaus
www.americanbankingnews.com - October 22 at 2:52 PM |
| Biogen (NASDAQ:BIIB) Price Target Increased to $310.00 by Analysts at Jefferies Financial Group
www.americanbankingnews.com - October 22 at 2:52 PM |
| Cramer: Biogen's Alzheimer's treatment would be 'the biggest drug ever' - CNBC
www.cnbc.com - October 22 at 2:20 PM |
 | Biogen’s stock blasts off after surprise reversal on Alzheimer’s drug, earnings beat
www.marketwatch.com - October 22 at 11:12 AM |
| Biogen (NASDAQ:BIIB) Rating Reiterated by Cowen
www.americanbankingnews.com - October 22 at 9:33 AM |
| Company says it will seek approval of Alzheimer's drug
marketbeat.com - October 22 at 9:29 AM |
| Biogen (NASDAQ:BIIB) Earns Hold Rating from Mizuho
www.americanbankingnews.com - October 22 at 8:41 AM |
| Biogen Earnings, Revenue Beat in Q3 - Yahoo Finance
finance.yahoo.com - October 22 at 7:57 AM |
 | Neurimmune Welcomes Biogen's News on Clinical Benefit of Aducanumab - PRNewswire
www.prnewswire.com - October 22 at 7:57 AM |
 | Form 8-K BIOGEN INC. For: Oct 22 - StreetInsider.com
www.streetinsider.com - October 22 at 7:57 AM |
| Biogen says it will pursue FDA approval of early Alzheimer's drug - MarketWatch
www.marketwatch.com - October 22 at 7:57 AM |
| Biogen resurrects Alzheimer's drug; shares jump 35% - Reuters
www.reuters.com - October 22 at 7:57 AM |
| Biogen Surges After Announcing Plans to Pursue Alzheimer's Drug Approval
finance.yahoo.com - October 22 at 7:57 AM |
| Biogen Plans Regulatory Filing for Aducanumab in Alzheimer’s Disease Based on New Analysis of Larger Dataset from Phase 3 Studies
finance.yahoo.com - October 22 at 7:57 AM |
| Biogen says it will pursue FDA approval of early Alzheimer's drug
finance.yahoo.com - October 22 at 7:57 AM |
| Biogen's stock rockets after earnings beat, Alzheimer's treatment heads for regulatory approval process
finance.yahoo.com - October 22 at 7:57 AM |
| Biogen to seek Alzheimer’s drug approval
finance.yahoo.com - October 22 at 7:57 AM |
| Biogen Surges as Momentum for Alzheimer’s Treatment Revives Hope
finance.yahoo.com - October 22 at 7:57 AM |
